{"duration": 0.0003237724304199219, "input_args": {"examples": "{'document_id': ['0000001', '0000001', '0000001', '0000001'], 'document_source': ['NIHSeniorHealth', 'NIHSeniorHealth', 'NIHSeniorHealth', 'NIHSeniorHealth'], 'document_url': ['http://nihseniorhealth.gov/agerelatedmaculardegeneration/toc.html', 'http://nihseniorhealth.gov/agerelatedmaculardegeneration/toc.html', 'http://nihseniorhealth.gov/agerelatedmaculardegeneration/toc.html', 'http://nihseniorhealth.gov/agerelatedmaculardegeneration/toc.html'], 'category': [None, None, None, None], 'umls_cui': ['C0242383', 'C0242383', 'C0242383', 'C0242383'], 'umls_semantic_types': ['T047', 'T047', 'T047', 'T047'], 'umls_semantic_group': ['Disorders', 'Disorders', 'Disorders', 'Disorders'], 'synonyms': [None, None, None, None], 'question_id': ['0000001-26', '0000001-27', '0000001-29', '0000001-32'], 'question_focus': ['Age-related Macular Degeneration', 'Age-related Macular Degeneration', 'Age-related Macular Degeneration', 'Age-related Macular Degeneration'], 'question_type': ['prevention', 'treatment', 'research', 'information'], 'question': ['How to prevent Age-related Macular Degeneration ?', 'What are the treatments for Age-related Macular Degeneration ?', 'what research (or clinical trials) is being done for Age-related Macular Degeneration ?', 'What is (are) Age-related Macular Degeneration ?'], 'answer': ['There is no reason for those diagnosed with early stage AMD to take the AREDS formulation. The study did not find that the formulation helped those with early stage AMD. If you have early stage AMD, a comprehensive dilated eye exam every year can help determine if the disease is progressing. If early stage AMD progresses to the intermediate stage, discuss taking the formulation with your doctor.', 'Wet AMD can be treated with laser surgery, photodynamic therapy, and drugs that are injected into the eye. None of these treatments is a cure for wet AMD. The disease and loss of vision may progress despite treatment.', 'The National Eye Institute scientists are - studying the possibility of transplanting healthy cells into a diseased retina   - evaluating families with a history of AMD to understand genetic and hereditary factors that may cause the disease  - looking at certain anti-inflammatory treatments for the wet form of AMD. studying the possibility of transplanting healthy cells into a diseased retina evaluating families with a history of AMD to understand genetic and hereditary factors that may cause the disease looking at certain anti-inflammatory treatments for the wet form of AMD. This research should provide better ways to detect, treat, and prevent vision loss in people with AMD.', 'National Eye Institute  National Institutes of Health  2020 Vision Place  Bethesda, MD 20892-3655  301-496-5248  E-mail: 2020@nei.nih.gov  www.nei.nih.gov Association for Macular Diseases  210 East 64th Street, 8th Floor  New York, NY 10021-7471  212-605-3719 Foundation Fighting Blindness  Executive Plaza 1, Suite 800  11435 Cronhill Drive  Owings Mill, MD 21117-2220  1-888-394-3937  410-785-1414 Macular Degeneration Partnership  6222 Wilshire Boulevard, Suite 260  Los Angeles, CA 90048  1-888-430-9898  310-623-4466  www.amd.org']}"}, "time": 1746283467.873106}